Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Antoine C, Müller S, Cant A et al. (2003) Long term survival and hematopoietic stem-cell transplantation for immunodeficiencies: a survey of the European experience, 1968–1999. Lancet 361: 553–560

    Article  PubMed  Google Scholar 

  • Bordignon C, Notarangelo L D, Nobili N et al. (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470–475

    CAS  PubMed  Google Scholar 

  • Buckley RH, Fischer A (1999) Bone marrow transplantation for primary immunodeficiency diseases. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 459–475

    Google Scholar 

  • Candotti F, Blaese RM (1999) Gene therapy. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 476–489

    Google Scholar 

  • CDC (1993) Recommendations of the Advisory Committee on immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 42(RR-4): 1–18

    Google Scholar 

  • Conley ME, Stiehm ER (1996) Immunodeficiency disorders: general considerations. In: Stiehm ER (ed) Immunologic disorders in infants and children, 4th edn. WB Saunders, Philadelphia, pp 201–252

    Google Scholar 

  • Busse PJ, Razvi S, Cunningham-Rundles C (2002) Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immuno deficiency. J Allergy Clin Immunol 109:1001–1004

    Article  CAS  PubMed  Google Scholar 

  • Garbett ND, Currie DC, Cole PJ (1989) Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammablobulinaemia. J Clin Exp Immunol 76:1–7

    CAS  Google Scholar 

  • Gardulf A, Anderson V, Bjorkander J et al. (1995) Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345:365–369

    CAS  PubMed  Google Scholar 

  • Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky BH (1996) Chronic granulomatous disease in adults. Lancet 347:220–3

    Article  CAS  PubMed  Google Scholar 

  • Stiehm ER (1999) Conventional therapy of primary immunodeficiency diseases. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 448–458

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Grimbacher, B., Wintergerst, U. (2005). Primäre Immundefekte. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics